Please use this identifier to cite or link to this item:
https://hdl.handle.net/10316/105224
Title: | Awareness of the Causes Leading to Surgical Ablation of Ovarian Function in Premenopausal Breast Cancer-A Single-Center Analysis | Authors: | Oliveira, Joana Correia Sousa, Filipa Costa Gante, Inês Dias, Margarida Figueiredo |
Keywords: | breast cancer; receptor; estrogen; salpingo-oophorectomy; antineoplastic agents; hormonal; neoplasms; hormone-dependent | Issue Date: | 16-Apr-2021 | Publisher: | MDPI AG | metadata.degois.publication.title: | Medicina (Lithuania) | metadata.degois.publication.volume: | 57 | metadata.degois.publication.issue: | 4 | Abstract: | Background and Objectives: Ovarian surgical ablation (OSA) in estrogen receptor-positive (ER+) breast cancer is usually performed to halt ovarian function in premenopausal patients. Since alternative pharmacological therapy exists and few studies have investigated why surgery is still performed, we aimed to analyze the reasons for the use of OSA despite the remaining controversy. Materials and Methods: Premenopausal ER+ breast cancer patients treated at a tertiary center (2005-2011) were selected, and patients with germline mutations were excluded. Results: Seventy-nine patients met the inclusion criteria. Globally, the main reasons for OSA included: continued menstruation despite hormone therapy with or without ovarian medical ablation (OMA) (34.2%), patient informed choice (31.6%), disease progression (16.5%), gynecological disease requiring surgery (13.9%), and tamoxifen intolerance/contraindication (3.8%). In women aged ≥45 years, patient choice was significantly more frequently the reason for OSA (47.4% versus 17.1% (p = 0.004)). For those aged <45 years, salvation attempts were significantly more frequent as compared to older women (26.8% versus 5.3% (p = 0.01)). In 77.8% of women undergoing OSA with menstrual cycle maintenance, surgery was performed 1-5 years after diagnosis, while surgery was performed earlier (0-3 months after diagnosis) in patients undergoing OSA as an informed choice (56.0%), as a salvation attempt (53.8%), or due to gynecological disease (63.6%). The leading reason for OSA in women previously undergoing OMA was continued menstruation (60.0%). Conclusions: This study suggests a possible failure of pharmacological ovarian suppression and reinforces the need for shared decision-making with patients when discussing treatment strategies, although validation by further studies is warranted due to our limited sample size. | URI: | https://hdl.handle.net/10316/105224 | ISSN: | 1648-9144 | DOI: | 10.3390/medicina57040385 | Rights: | openAccess |
Appears in Collections: | FMUC Medicina - Artigos em Revistas Internacionais |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Awareness-of-the-causes-leading-to-surgical-ablation-of-Ovarian-function-in-premenopausal-breast-cancerA-singlecenter-analysisMedicina-Lithuania.pdf | 325.62 kB | Adobe PDF | View/Open |
SCOPUSTM
Citations
1
checked on Oct 28, 2024
WEB OF SCIENCETM
Citations
1
checked on Oct 2, 2024
Page view(s)
90
checked on Nov 5, 2024
Download(s)
65
checked on Nov 5, 2024
Google ScholarTM
Check
Altmetric
Altmetric
This item is licensed under a Creative Commons License